指南与共识产科母胎医学

母胎医学会咨询系列第72号:双胎输血综合征与双胎贫血-红细胞增多序列征

Society for Maternal-Fetal Medicine Consult Series #72: Twin-twin transfusion syndrome and twin anemia-polycythemia sequence.
指南 / 共识 · Am J Obstet Gynecol · 2024-07-18

该咨询回顾了单绒毛膜双胎妊娠中双胎输血综合征与双胎贫血-红细胞增多序列征的总体考虑与当代处理方法,基于现有证据提供管理推荐。母胎医学会共给出14条推荐,涵盖绒毛膜性/羊膜性早期超声判定、16周起每2周超声监测、胎儿镜下激光手术作为II至IV期标准治疗、激光术后监测与分娩时机、双胎贫血-红细胞增多序列征的产前诊断标准等。

要点

  • 推荐所有单绒毛膜双羊膜囊双胎妊娠自16周起至少每2周超声监测双胎输血综合征直至分娩(GRADE 1C)。
  • 推荐胎儿镜下激光手术作为16至26周就诊的II至IV期双胎输血综合征的标准治疗(GRADE 1A)。
  • 双胎贫血-红细胞增多序列征产前诊断至少需供血儿大脑中动脉收缩期峰值流速>1.5倍中位数且受血儿<1.0倍中位数,或双胎间Δ大脑中动脉收缩期峰值流速>0.5倍中位数(GRADE 1C)。

核心结论

  • 该咨询基于现有证据提供双胎输血综合征与双胎贫血-红细胞增多序列征的当代管理推荐,共14条推荐。

研究设计与样本

  • 母胎医学会咨询系列,基于现有证据提供管理推荐。

主要发现

  • 自发性双胎中30%为单卵双胎,其中三分之二为单绒毛膜双胎,共用一个胎盘。
  • 共用胎盘块与双胎间共享胎盘循环是单绒毛膜妊娠特有并发症发生与管理的核心。

关键数值与推荐

  • 推荐常规早孕期超声判定绒毛膜性与羊膜性(GRADE 1B)。
  • 推荐所有单绒毛膜双羊膜囊双胎妊娠自16周起开始双胎输血综合征超声监测,至少每2周一次直至分娩,临床担忧时增加监测频率(GRADE 1C)。
  • 推荐双胎输血综合征常规超声监测至少包括评估双胎间隔膜两侧羊水量及有无充盈尿液的胎儿膀胱,理想情况下纳入脐动脉多普勒检查(GRADE 1C)。
  • 推荐胎儿镜下激光手术作为16至26周就诊的II至IV期双胎输血综合征的标准治疗(GRADE 1A)。
  • 推荐对继续妊娠的无症状I期双胎输血综合征患者采取期待管理并至少每周胎儿监测,对16至26周就诊且合并母体羊水过多相关症状等额外因素的I期双胎输血综合征考虑胎儿镜下激光手术(GRADE 1B)。

临床怎么用

  • 所有单绒毛膜双羊膜囊双胎妊娠自16周起至少每2周超声监测双胎输血综合征直至分娩(GRADE 1C)。
  • 符合激光治疗条件的双胎输血综合征患者应转诊至胎儿干预中心(Best Practice)。
  • 激光术后每周监测6周后恢复每两周监测,除非有特定担忧(GRADE 2C)。
  • 双胎输血综合征缓解后双胎存活者推荐34至36周分娩(GRADE 1C);治疗后单胎死亡者存活儿推荐39周分娩(GRADE 1C)。
  • 提供者可考虑自16周起将大脑中动脉收缩期峰值流速测定纳入所有单绒毛膜双胎超声监测(GRADE 1C)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Thirty percent of spontaneously occurring twins are monozygotic, of which two-thirds are monochorionic, possessing a single placenta. A common placental mass with shared intertwin placental circulation is key to the development and management of complications unique to monochorionic gestations. In this Consult, we review general considerations and a contemporary approach to twin-twin transfusion syndrome and twin anemia-polycythemia sequence, providing management recommendations based on the available evidence. The following are the Society for Maternal-Fetal Medicine recommendations: (1) we recommend routine first-trimester sonographic determination of chorionicity and amnionicity (GRADE 1B); (2) we recommend that ultrasound surveillance for twin-twin transfusion syndrome begin at 16 weeks of gestation for all monochorionic-diamniotic twin pregnancies and continue at least every 2 weeks until delivery, with more frequent monitoring indicated with clinical concern (GRADE 1C); (3) we recommend that routine sonographic surveillance for twin-twin transfusion syndrome minimally include assessment of amniotic fluid volumes on both sides of the intertwin membrane and evaluation for the presence or absence of urine-filled fetal bladders, and ideally incorporate Doppler study of the umbilical arteries (GRADE 1C); (4) we recommend fetoscopic laser surgery as the standard treatment for stage II through stage IV twin-twin transfusion syndrome presenting between 16 and 26 weeks of gestation (GRADE 1A); (5) we recommend expectant management with at least weekly fetal surveillance for asymptomatic patients continuing pregnancies complicated by stage I twin-twin transfusion syndrome, and consideration for fetoscopic laser surgery for stage I twin-twin transfusion syndrome presentations between 16 and 26 weeks of gestation complicated by additional factors such as maternal polyhydramnios-associated symptomatology (GRADE 1B); (6) we recommend an individualized approach to laser surgery for early- and late-presenting twin-twin transfusion syndrome (GRADE 1C); (7) we recommend that all patients with twin-twin transfusion syndrome qualifying for laser therapy be referred to a fetal intervention center for further evaluation, consultation, and care (Best Practice); (8) after laser therapy, we suggest weekly surveillance for 6 weeks followed by resumption of every-other-week surveillance thereafter, unless concern exists for post-laser twin-twin transfusion syndrome, post-laser twin anemia-polycythemia sequence, or fetal growth restriction (GRADE 2C); (9) following the resolution of twin-twin transfusion syndrome after fetoscopic laser surgery, and without other indications for earlier delivery, we recommend delivery of dual-surviving monochorionic-diamniotic twins at 34 to 36 weeks of gestation (GRADE 1C); (10) in twin-twin transfusion syndrome pregnancies complicated by posttreatment single fetal demise, we recommend full-term delivery (39 weeks) of the surviving co-twin to avoid complications of prematurity unless indications for earlier delivery exist (GRADE 1C); (11) we recommend that fetoscopic laser surgery not influence the mode of delivery (Best Practice); (12) we recommend that prenatal diagnosis of twin anemia-polycythemia sequence minimally require either middle cerebral artery Doppler peak systolic velocity values >1.5 and <1.0 multiples of the median in donor and recipient twins, respectively, or an intertwin Δ middle cerebral artery peak systolic velocity >0.5 multiples of the median (GRADE 1C); (13) we recommend that providers consider incorporating middle cerebral artery Doppler peak systolic velocity determinations into all monochorionic twin ultrasound surveillance beginning at 16 weeks of gestation (GRADE 1C); and (14) consultation with a specialized fetal care center is recommended when twin anemia-polycythemia sequence progresses to a more advanced disease stage (stage ≥II) before 32 weeks of gestation or when concern arises for coexisting complications such as twin-twin transfusion syndrome (Best Practice).

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Miller RS, Miller JL, Monson MA, et al. Society for Maternal-Fetal Medicine Consult Series #72: Twin-twin transfusion syndrome and twin anemia-polycythemia sequence. Am J Obstet Gynecol. 2024. PMID: 39029545. doi:10.1016/j.ajog.2024.07.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。